(Q33940873)

30 July 2017

1 reference

title

Kynurenic acid antagonists and kynurenine pathway inhibitors (English)

1 reference

30 July 2017

Stone TW

1

0 references

language of work or name

English

0 references

publication date

1 April 2001

1 reference

Expert Opinion on Investigational Drugs

30 July 2017

published in

1 reference

30 July 2017

volume

10

1 reference

30 July 2017

issue

4

1 reference

30 July 2017

page(s)

633-645

1 reference

An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid.

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

NMDA receptors and ligands in the vertebrate CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

Kynurenic acid antagonises responses to NMDA via an action at the strychnine-insensitive glycine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

Actions of excitatory amino acids and kynurenic acid in the primate hippocampus: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

Sensitivity of hippocampal neurones to kainic acid, and antagonism by kynurenate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

Comparison of kynurenic acid and 2-APV suppression of epileptiform activity in rat hippocampal slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

Human macrophages convert L-tryptophan into the neurotoxin quinolinic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

Human microglia convert l-tryptophan into the neurotoxin quinolinic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

The role of hydrogen peroxide in the in vitro cytotoxicity of 3-hydroxykynurenine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

Role of kynurenines in the neurotoxic actions of kainic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

Oxidative stress as a mechanism for quinolinic acid-induced hippocampal damage: protection by melatonin and deprenyl

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

Effects of central and peripheral administration of kynurenic acid on hippocampal evoked responses in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

Inhibition of excitatory neurotransmission with kynurenate reduces brain edema in neonatal anoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

Kynurenate inhibition of cell excitation decreases stroke size and deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

4-[(Carboxymethyl)oxy]- and 4-[(carboxymethyl)amino]-5,7-dichloroquinoline-2-carboxylic acid: new antagonists of the strychnine-insensitive glycine binding site on the N-methyl-D-aspartate receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

Kynurenic acid derivatives. Structure-activity relationships for excitatory amino acid antagonism and identification of potent and selective antagonists at the glycine site on the N-methyl-D-aspartate receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

Structural requirements for the development of potent N-methyl-D-aspartic acid (NMDA) receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

Competitive antagonism of glycine at the N-methyl-d-aspartate (NMDA) receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

4-substituted-3-phenylquinolin-2(1H)-ones: acidic and nonacidic glycine site N-methyl-D-aspartate antagonists with in vivo activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

3'-(Arylmethyl)- and 3'-(aryloxy)-3-phenyl-4-hydroxyquinolin-2(1H)-ones: orally active antagonists of the glycine site on the NMDA receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

Binding of the radiolabeled glycine site antagonist [3H]MDL 105,519 to homomeric NMDA-NR1a receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

Indole-2-carboxylates, novel antagonists of the N-methyl-D-aspartate (NMDA)-associated glycine recognition sites: in vivo characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

3-(2-carboxyindol-3-yl)propionic acid derivatives: antagonists of the strychnine-insensitive glycine receptor associated with the N-methyl-D-aspartate receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

Novel indole-2-carboxylates as ligands for the strychnine-insensitive N-methyl-D-aspartate-linked glycine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

Neuroprotective effects of RPR 104632, a novel antagonist at the glycine site of the NMDA receptor, in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

Nicotinylalanine increases cerebral kynurenic acid content and has anticonvulsant activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

Modulation of Quinolinic and Kynurenic Acid Content in the Rat Brain: Effects of Endotoxins and Nicotinylalanine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

Kynurenine hydroxylase inhibitors reduce ischemic brain damage: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(nitrophenyl)thiazol-2yl]-benzenesulfonamide (Ro 61-8048) in models of focal or global brain ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

(R,S)-3,4-dichlorobenzoylalanine (FCE 28833A) causes a large and persistent increase in brain kynurenic acid levels in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

Synthesis and biochemical evaluation of N-(4-phenylthiazol-2-yl)benzenesulfonamides as high-affinity inhibitors of kynurenine 3-hydroxylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

Synthesis and SAR of 4-aryl-2-hydroxy-4-oxobut-2-enoic acids and esters and 2-amino-4-aryl-4-oxobut-2-enoic acids and esters: potent inhibitors of kynurenine-3-hydroxylase as potential neuroprotective agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

4-Halo-3-hydroxyanthranilic acids: Potent competitive inhibitors of 3-hydroxy-anthranilic acid oxygenase in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

4-chloro-3-hydroxyanthranilate inhibits brain 3-hydroxyanthranate oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

6-Chloro-D,L-tryptophan, 4-chloro-3-hydroxyanthranilate and dexamethasone attenuate quinolinic acid accumulation in brain and blood following systemic immune activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

Effects of the 3-hydroxyanthranilic acid analogue NCR-631 on anoxia-, IL-1 beta- and LPS-induced hippocampal pyramidal cell loss in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

Inhibition of nitric oxide synthase expression and activity in macrophages by 3-hydroxyanthranilic acid, a tryptophan metabolite

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

Pharmacology of ACEA-1416: a potent systemically active NMDA receptor glycine site antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

Synthesis and structure-activity relationships of substituted 1,4-dihydroquinoxaline-2,3-diones: antagonists of N-methyl-D-aspartate (NMDA) receptor glycine sites and non-NMDA glutamate receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

ACEA 1021, a glycine site antagonist with minor psychotomimetic and amnestic effects in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

N-methyl-D-aspartate antagonists for stroke and head trauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

Glycine site antagonist attenuates infarct size in experimental focal ischemia. Postmortem and diffusion mapping studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

Cerebrospinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

Increased ratio of quinolinic acid to kynurenic acid in cerebrospinal fluid of D retrovirus-infected rhesus macaques: relationship to clinical and viral status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

Efficacy of memantine, an NMDA receptor antagonist, in the treatment of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

Glutamate antagonists and Parkinson's disease: a review of clinical data

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

NMDA-associated glycine binding site increases in schizophrenic brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

Increases in strychnine-insensitive glycine binding sites in cerebral cortex of chronic schizophrenics: evidence for glutamate hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

R-(+)-HA-966, a glycine/NMDA receptor antagonist, selectively blocks the activation of the mesolimbic dopamine system by amphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

Focal microinjection of gamma-acetylenic GABA into the rat entorhinal cortex: behavioral and electroencephalographic abnormalities and preferential neuron loss in layer III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

gamma-Acetylenic GABA produces axon-sparing neurodegeneration after focal injection into the rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

Focal injection of aminooxyacetic acid produces seizures and lesions in rat hippocampus: Evidence for mediation by NMDA receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

Neuronal damage after the injection of aminooxyacetic acid into the rat entorhinal cortex: a silver impregnation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

Aminooxyacetic acid causes selective neuronal loss in layer III of the rat medial entorhinal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

Lamotrigine-antiparkinsonian activity by blockade of glutamate release?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

Phosphonate analogues of carboxylic acids as aminoacid antagonists on rat cortical neurones

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

Glycine potentiates the NMDA response in cultured mouse brain neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.633

10.1517/13543784.10.4.633

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference